Rht Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 3.96%
(FY 2021)
- Profit 7.21%
(FY 2021)
- Ebitda -350.41%
(FY 2021)
- Net Worth 36.11%
(FY 2021)
- Total Assets -29.72%
(FY 2021)
About Rht Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Riteshkumar Thakkar and Sangeetaben Thakkar serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC073003
- Company No.
073003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rht Pharmaceuticals Private Limited offer?
Rht Pharmaceuticals Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Antibiotic Tablets & Capsules, Cefixime Tablet, Pain Reliever Gel, Diclofenac Diethylamine Gel.
Who are the key members and board of directors at Rht Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Riteshkumar Thakkar  | Director | 14-Dec-2012 | Current |
| Sangeetaben Thakkar | Director | 24-Nov-2015 | Current |
Financial Performance of Rht Pharmaceuticals.
Rht Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.96% increase. The company also saw a slight improvement in profitability, with a 7.21% increase in profit. The company's net worth Soared by an impressive increase of 36.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rht Pharmaceuticals?
In 2021, Rht Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Duphar Lifesciences Private LimitedActive 15 years 9 monthsRiteshkumar Thakkar and Sangeetaben Thakkar are mutual person
- Roussel Laboratories Private LimitedActive 16 years 11 months
Riteshkumar Thakkar and Sangeetaben Thakkar are mutual person
- Duphar Bioscience Private LimitedActive 13 years 6 months
Riteshkumar Thakkar and Sangeetaben Thakkar are mutual person
- Greatlee Pharmaceuticals Private LimitedActive 2 years 10 months
Riteshkumar Thakkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rht Pharmaceuticals?
Unlock and access historical data on people associated with Rht Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rht Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rht Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
